Medicines planning
47 results
Applied filters
Biosimilar and key generic medicines – June 2026 update
25 June 2026An update about biosimilar and key generic medicines to support system planning and mobilisation
Preparing to use omalizumab biosimilar
20 July 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. We offer general information and implementation advice.
Biosimilar and key generic medicines – September 2026 update
16 September 2026An update around biosimilar and key generic medicines to support system planning and mobilisation.
Biosimilars
Regularly updated material to support the introduction of aflibercept, golimumab, ranibizumab, ustekinumab and other biosimilars of interest.
Using our annual medicines planning publication, Prescribing Outlook
14 August 2026Users should be aware of the constraints and assumptions in creating Prescribing Outlook, as well as their responsibilities for use.
Annual medicines planning
Our annual Prescribing Outlook output supports planning, implementation and budget planning for medicines every year.
Annual medicines planning publication, Prescribing Outlook
24 August 2026Our annual output ‘PO’ supports managed entry and budget planning for new medicines, new indications and medicines with loss of exclusivity in the NHS.